James M Reuben
Overview
Explore the profile of James M Reuben including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
6906
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez R, Willey J, et al.
JAMA Oncol
. 2018 Jun;
4(9):1207-1213.
PMID: 29879283
Importance: Combining conventional chemotherapy with targeted therapy has been proposed to improve the pathologic complete response (pCR) rate in patients with inflammatory breast cancer (IBC). Epidermal growth factor receptor (EGFR)...
32.
Reddy J, Atkinson R, Larson R, Burks J, Smith D, Debeb B, et al.
Breast Cancer Res Treat
. 2018 Jun;
171(2):283-293.
PMID: 29858753
Introduction: We hypothesized that breast tissue not involved by tumor in inflammatory breast cancer (IBC) patients contains intrinsic differences, including increased mammary stem cells and macrophage infiltration, which may promote...
33.
Lim B, Woodward W, Wang X, Reuben J, Ueno N
Nat Rev Cancer
. 2018 May;
18(8):526.
PMID: 29748602
The originally published article contained an error in Table 1, in which two neoadjuvant clinical trials (NCT02876107 and NCT03101748) were not included. This omission has been corrected in the online...
34.
Lim B, Woodward W, Wang X, Reuben J, Ueno N
Nat Rev Cancer
. 2018 Apr;
18(8):485-499.
PMID: 29703913
Inflammatory breast cancer (IBC) is a rare and aggressive disease that accounts for ~2-4% of all breast cancers. However, despite its low incidence rate, IBC is responsible for 7-10% of...
35.
Woodward W, Cristofanilli M, Merajver S, Van Laere S, Pusztai L, Bertucci F, et al.
J Cancer
. 2018 Apr;
8(17):3607-3614.
PMID: 29667990
In 2006, a remarkable collaboration between University of Texas MD Anderson Cancer Center clinicians and Texas and New Mexico State legislators led to the formation of a dedicated IBC Research...
36.
Alvarez R, Bechara R, Naughton M, Adachi J, Reuben J
Oncologist
. 2018 Mar;
23(6):660-669.
PMID: 29487226
Implications For Practice: This article summarizes the pathogenesis, clinical presentation, incidence, detection, and optimal management of everolimus-related noninfectious pneumonitis in breast cancer. In particular, this article provides a detailed overview...
37.
Rahal O, Wolfe A, Mandal P, Larson R, Tin S, Jimenez C, et al.
Int J Radiat Oncol Biol Phys
. 2018 Feb;
100(4):1034-1043.
PMID: 29485045
Purpose: To determine the role of macrophage polarization on the response of inflammatory breast cancer (IBC) cells to radiation and whether modulation of macrophage plasticity can alter radiation response. Methods...
38.
Yamauchi T, Fernandez J, Imamura C, Yamauchi H, Jinno H, Takahashi M, et al.
Oncotarget
. 2018 Feb;
9(6):6872-6882.
PMID: 29467936
Chemotherapy has been reported to increase the proportion of cancer stem cells (CSCs) and to promote epithelial-mesenchymal transition (EMT) phenotype changes. Anti-HER2 therapy may provide a strategy for eliminating CSC...
39.
Wang X, Reyes M, Zhang D, Funakoshi Y, Trape A, Gong Y, et al.
Oncotarget
. 2017 Oct;
8(40):67904-67917.
PMID: 28978083
Inflammatory breast cancer (IBC) is the most lethal and aggressive type of breast cancer, with a strong proclivity to metastasize, and IBC-specific targeted therapies have not yet been developed. Epidermal...
40.
Fujii T, Reuben J, Huo L, Fernandez J, Gong Y, Krupa R, et al.
PLoS One
. 2017 Sep;
12(9):e0185231.
PMID: 28957377
Purpose: Androgen receptor (AR) is frequently detected in breast cancers, and AR-targeted therapies are showing activity in AR-positive (AR+) breast cancer. However, the role of AR in breast cancers is...